BackFreeline Therapeutics Holdings plc Overview

Freeline Therapeutics Holdings plc Profit Margin

Latest profit margin for Freeline Therapeutics Holdings plc: -8027.65% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-241760.00%

As of Sep 2023

Annual Profit Margin (TTM)

-8027.65%

Trailing 12 months ending Sep 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Freeline Therapeutics Holdings plc (FRLN) FAQ

As of the most recent data (September 2023), FRLN shows a profit margin of -8027.65%. That is below the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average profit margin is about 21.34%. Freeline Therapeutics Holdings plc is at -8027.65%, which is lower that average. That is roughly 37726.3% below the sector mean. Use the comparison chart on this page to see how FRLN stacks up against individual peers as well.

Check the historical chart to see whether FRLN's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Freeline Therapeutics Holdings plc with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Freeline Therapeutics Holdings plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -8027.65%) with ownership activity and broader fundamentals.

The Healthcare average profit margin is about 21.34%, while FRLN is at -8027.65%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.